SCHEMBL30041556

SCHEMBL30041556

Nc1cc(SCc2nc3cc(Nc4ccccc4)ccc3[nH]2)cc(C(F)(F)F)n1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.43
▸ RAB9A P51151 3/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ ABCB1 P08183 12/20 0.40
▸ ALDH1A1 P00352 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ PARP14 Q460N5 2/20 0.36
▸ NTRK1 P04629 1/20 0.35
▸ NTRK2 Q16620 1/20 0.35
▸ ERBB2 P04626 1/20 0.34
▸ THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26260607 1.00 NPC1 (0.43) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL30040840 0.92 ABCB1 (0.42) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL26260525 0.92 ABCB1 (0.42) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL30040786 0.90 KIF11 (0.41) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL26260626 0.90 KIF11 (0.41) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL23618336 0.85 NPC1 (0.44) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL21611960 0.82 NPC1 (0.43) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL26260609 0.82 ABCB1 (0.40) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL26261620 0.78 ABCB1 (0.35) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4
SCHEMBL26261019 0.78 ABCB1 (0.51) NPC1RAB9ASMN1; SMN2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085054-B1 NEW PQSR INVERSE AGONISTS HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) 2025-02-19 — — EP disclosed
EP-4085054-A1 NEW PQSR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2022-11-09 — — EP disclosed
Send feedback